Stream: Computational Health
Greg Bullington is the chief executive officer, co-founder, and a member of Magnolia Medical’s board. Greg has led all aspects of company development since inception, including clinical trial design, execution, and publication; broad product portfolio development; creation of a new national standard of care for sepsis testing accuracy; rapid revenue growth commercialization; and intellectual property and enforcement strategy. To date, Greg has raised over $125M to drive the successful seeding, development, and growth of the novel multibillion-dollar ISDD® market that he and his team invented and created.
Greg has extensive experience in the healthcare industry and has led product commercialization and strategy engagements for a wide variety of companies in the biotech and immunotherapy as well as healthcare insurance, wellness, and enterprise software sectors.
Greg began his career in professional services with Deloitte & Touche LLP. He continued his professional development as a management consultant at Lake Partners, a Seattle-based strategy consulting firm. In 2006, Greg founded Forum Ventures, a technology commercialization consultancy focused on accelerating the growth of early and mid-stage companies in a variety of sectors. Over the past 22 years, Greg has led engagements and worked closely with senior executive teams at over 50 companies ranging from Fortune 100 corporations to venture-backed and early-stage startups as a consultant, advisor, and investor. Additionally, Greg has significant intellectual property expertise. He is the first named inventor on more than 100 issued patents, as well as over 50 pending U.S. and international patent applications.
Greg is a member of YPO and serves on the YPO Seattle Board. He also serves as a founding member on the board of Wunderground Coffee. In addition to his board positions, Greg volunteers his time to support new entrepreneurs and philanthropic causes. He is the founder and chairman of the Kyle Charvat Foundation, an all-volunteer, non-profit organization providing financial assistance to young adults with life-threatening cancer. In 2023, Greg was selected as a finalist for Ernst & Young’s (EY) Entrepreneur of the Year program.